Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research



Lime (Citrus aurantifolia L.) Juice a Potent Treatment for the Virulent Hepatocarcinogen Aflatoxin B1 in Peanut Paste

Esameldin Bashir Mohamed Kabbashi, Salah Eldeen Abbas Ali, Nawal Abdelgayoum Abdelrahman.

Abstract
The Aflatoxins are fungal toxins and products of Aspergillus flavus and A. niger. They include B aflatoxins (B1, the most potent hepatocarcinogen known, and B2) which are produced by both species and aflatoxins G (G1 and G2) that are produced by A. niger and aflatoxin M1 and Q1 metabolites of B1 and aflatoxin M2 metabolite of Aflatoxin B2. Since the discovery of aflatoxins in 1960, after an outbreak of a disease of unknown etiology of turkey in England, the scientific approach towards these toxins concentrated on the protective measures and control of the incidence of these carcinogens either.
Objective: This study aimed at coming out with a remedy and curing for elimination of aflatoxin B1 in peanut paste. The importance of this stemmed from the fact that aflatoxin occurrence is rather inevitable considering all the advancements in the protective measures.
Methods: However, since the incidence of these toxins is rather unavoidable countable attempts were done on the treatment of these toxins in food and feed stuffs. Accordingly this fact persuaded testing some easy and familiar culinary approaches to mitigate and/ or perhaps diminish the presence of aflatoxin B1 (AFLB1) in the commonly consumed peanut (Arachis hypogaea L.) paste. Lime juice, in two doses (12.5 and 25 ml/ g), was applied to 25 g peanut paste contained AFLB1 (7.53 ppb) and stored for 1, 3 and 7 days. The test material was then analyzed for AFLB1 using aflatest® HPLC column of Vicam® of Waters corporation and HPLC Shimatzu® brand.
Results: The collected data of the test samples reflected a reduction in AFLB1, due to the doses of 12.5 and 25 ml lime juice, of 11% and 31%, respectively (for one day storage), 54% and 66%, respectively (for 3 days storage), and 74% and 92% (for 7 days storage). Conclusions: These results are encouraging for use of lime juice as a treatment for aflatoxin B1 wherever applicable.

Key words: Aflatoxin B1, Lime Juice, Peanut Paste, Treatment.


Full-text options

Full-text Article


Share this Article


Readers of this article also read the following articles
»A survey on technical approaches in fall detection system
»EFFECT OF ANABAENA SUBCYLINDRICA FILTRATE ON THE GROWTH OF FABA BEAN CULTIVATED IN NON-INFESTED OR INFESTED SOIL BY RHIZOCTONIA SOLANI
»Neuroprotective effects of Indigofera tinctoria on noise stress affected Wistar albino rat brain
»Assessment of protective effect of ascorbic acid in cisplatin ototoxicity on guinea pigs with electrophysiological tests and ultrastructural study: A Preliminary Study
»Vegetative growth, chemical composition, and flavonoids content of Azadirachta indica plants as affected by application of yeast natural extract
»Optimization of cryoprotectants for Streptococcus thermophilus during freeze-drying using Box-Behnken experimental design
»MOLECULAR CHARACTERIZATION OF A MARINE KLEBSIELLA ISOLATE BY 16S RIBOSOMAL RNA GENE SEQUENCE AND OPTIMIZATION OF ITS EXOPOLYSACCHARIDE PRODUCTION
»Design and evaluation of Carvedilol nanocrystals sustained release tablets
»A Preliminary Pharmacognostical and Pharmaceutical Evaluation of Bala Chaturbhadra Avaleha
»Pharmacognostic Evaluation of Stem and Root of Taverniera nummularia Baker
»Bio-efficacy of medicinal plants used for the management of diabetes mellitus in Gabon. An ethnopharmacological approach



Advertisement
Applied Medical Research

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.